잠시만 기다려 주세요. 로딩중입니다.

한국의 새로운 인슐린 펌프와 오픈 소스 인공췌장

New Insulin Pumps and Open Source Artificial Pancreas System in Korea

Journal of Korean Diabetes 2020년 21권 4호 p.197 ~ 203
김재현,
소속 상세정보
김재현 ( Kim Jae-Hyeon ) - Sungkyunkwan University School of Medicine Samsung Medical Center Department of Medicine

Abstract


Diabetes technology that includes artificial pancreas system (APS) has achieved remarkable progress in the past decades. The first APS, the Medtronic MiniMed 670G system introduced in 2017, and other subsequent commercial APSs have come as answers to patient and clinician prayers. However, these devices are not accessible by most persons with type 1 diabetes (T1D) in Korea. Therefore, highly motivated, and tech-savvy persons in the diabetes community have started developing open source APS (Open APS) that integrate continuous glucose monitoring (CGM), insulin pumps, and smartphone technology to run their own do-it-yourself APS (DIYAPS). Observational studies have revealed significant improvements in HbA1c levels, time in range, and quality of life after the initiation of Open APS use. However, the use of regularized CGM and an insulin pump with an unauthorized DIYAPS makes these devices off-label and this has been a matter of grave clinical concern. In addition, lack of randomized controlled trials, insurance coverage, and legal issues are barriers to the general acceptance of DIYAPS among persons with T1D. In this article, I will summarize existing DIYAPS studies including those in Korea and their concerns. In addition, I will introduce new insulin pumps available in Korea.

키워드

Diabetes mellitus, type 1; Insulin; Pancreas; artificial

원문 및 링크아웃 정보

등재저널 정보